REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $263,386,239 | 53.13% |
| First Light Asset Management, LLC | 1,586,928 | $144,283,494 | 12.99% |
| Ghost Tree Capital, LLC | 300,000 | $27,276,000 | 8.06% |
| Perceptive Advisors | 2,169,276 | $197,230,574 | 5.82% |
| Boxer Capital, LLC | 1,230,004 | $111,832 | 5.49% |
| MPM BioImpact LLC | 176,874 | $16,544,794 | 4.30% |
| Sofinnova Investments, Inc. | 627,683 | $57,068,938 | 3.65% |
| KRS Capital Management, LLC | 28,141 | $2,558,580 | 2.88% |
| Deep Track Capital, LP | 729,000 | $66,280,680 | 2.72% |
| Ikarian Capital, LLC | 100,000 | $9,092,000 | 2.06% |
| LBJ Family Wealth Advisors, Ltd. | 29,907 | $2,719 | 1.91% |
| Ghost Tree Capital, LLC | 70,000 | $6,364,000 | 1.88% |
| Tri Locum Partners LP | 67,206 | $6,110,370 | 1.86% |
| Altium Capital Management LP | 35,000 | $3,182,200 | 1.77% |
| Ikarian Capital, LLC | 80,564 | $7,324,879 | 1.66% |
| Soleus Capital Management, L.P. | 174,592 | $15,873,905 | 1.64% |
| HighMark Wealth Management LLC | 21,269 | $1,933,777 | 1.51% |
| EMERALD ADVISERS, LLC | 314,621 | $28,605,341 | 1.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 255,018 | $23,186,237 | 1.37% |
| Artia Global Partners LP | 40,000 | $3,636,800 | 1.34% |
External links
This page lists REATA PHARMACEUTICALS INC's shareholders in Q1 2023. To view REATA PHARMACEUTICALS INC's shareholder history, click here.